{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:48:57Z","timestamp":1776127737716,"version":"3.50.1"},"reference-count":62,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2018,1,31]]},"DOI":"10.2217\/fon-2017-0334","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T10:54:11Z","timestamp":1512989651000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Atypical Chronic Myeloid Leukemia: A Rare Entity with Management Challenges"],"prefix":"10.1080","volume":"14","author":[{"given":"Prajwal","family":"Dhakal","sequence":"first","affiliation":[{"name":"Department of Medicine, Michigan State University, 788 Service Rd, East Lansing, MI48824, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Gundabolu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology & Oncology, University of Nebraska Medical Center, NE68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Amador","sequence":"additional","affiliation":[{"name":"Department of Pathology & Microbiology, University of Nebraska Medical Center, NE68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supratik","family":"Rayamajhi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Michigan State University, 788 Service Rd, East Lansing, MI48824, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology & Oncology, University of Nebraska Medical Center, NE68198, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"e_1_3_2_3_1","unstructured":"Vardiman JW BennettJM BainBJ BrunningRD. Atypical chronic myeloid leukaemia BCR-ABL1 negative. In: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues . SwerdlowSH CampoE Lee HarrisNet al.Eds). IARC Press Lyon France 80\u201381 (2008)."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"issue":"11","key":"e_1_3_2_5_1","first-page":"1566","article-title":"Identification of risk factors in atypical chronic myeloid leukemia","volume":"91","author":"Breccia M","year":"2006","unstructured":"Breccia M , BiondoF, LatagliataR, CarmosinoI, MandelliF, AlimenaG. Identification of risk factors in atypical chronic myeloid leukemia. Haematologica91(11), 1566\u20131568 (2006).","journal-title":"Haematologica"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10832"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704686"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01715120"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2011.01351.x"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-553800"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620715607416"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.1.205.205"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.11.2915"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008393002748"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.07.001"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24722"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.264"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.114660"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000021"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500959"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1670-3"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.113159"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2495"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-579466"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.133"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1898"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.2985"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.11.4683"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-693630"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12223"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14619"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11543"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.986477"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23018"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.122"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214514"},{"issue":"2","key":"e_1_3_2_37_1","first-page":"67","article-title":"Significant clinical response to JAK1\/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia","volume":"3","author":"Dao K-HT","year":"2014","unstructured":"Dao K-HT , SoltiMB, MaxsonJEet al. Significant clinical response to JAK1\/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leukemia Res. Rep.3(2), 67\u201369 (2014).","journal-title":"Leukemia Res. Rep."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25694"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1320"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2221-y"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-433821"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2451-7"},{"issue":"1","key":"e_1_3_2_43_1","first-page":"114","article-title":"The first case of decitabine successfully in treatment of atypical chronic myeloid leukemia with CEBPA double mutation","volume":"2","author":"Mao L","year":"2013","unstructured":"Mao L , YouL, YangM, LiY, YeX, TongH. The first case of decitabine successfully in treatment of atypical chronic myeloid leukemia with CEBPA double mutation. Chemotherapy2(1), 114 (2013).","journal-title":"Chemotherapy"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.294"},{"issue":"12","key":"e_1_3_2_45_1","first-page":"e414","article-title":"Durable disease control with MEK inhibition in a patient with NRAS-mutated atypical chronic myeloid leukemia","volume":"7","author":"Khanna V","year":"2015","unstructured":"Khanna V , PierceST, DaoKHet al. Durable disease control with MEK inhibition in a patient with NRAS-mutated atypical chronic myeloid leukemia. Cureus7(12), e414 (2015).","journal-title":"Cureus"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704472"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2013.48.3.178"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.26342"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1096341"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-016-0319-0"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24172"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.04.006"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.08.015"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647412"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0048"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215605662"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3977"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709114162"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.2.445.445"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6238"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.10.005"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2272-0"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70558-2"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4097"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2017-0334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:06Z","timestamp":1719125106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2017-0334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,31]]}},"alternative-id":["10.2217\/fon-2017-0334"],"URL":"https:\/\/doi.org\/10.2217\/fon-2017-0334","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}